Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21538
Abstract: Treatment of primary focal segmental glomerulosclerosis (FSGS) and its recurrence after kidney transplantation associated with rapid deterioration of kidney function remains to be challenging despite advances in immunosuppressive therapy. The presence of circulating factors has… read more here.
Keywords: focal segmental; glomerulosclerosis fsgs; using cytosorb; supar ... See more keywords
Evaluation of the relationship between KIM‐1 and suPAR levels and clinical severity in COVID‐19 patients: A different perspective on suPAR
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Medical Virology"
DOI: 10.1002/jmv.27099
Abstract: Coronavirus disease 2019 (COVID‐19) is one of the most pressing health problems of this century, but our knowledge of the disease is still limited. In this study, we aimed to examine serum‐soluble urokinase plasminogen activator… read more here.
Keywords: covid patients; evaluation relationship; kim supar; supar ... See more keywords
Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-019-01475-1
Abstract: BackgroundEarly risk stratification of patients with suspected acute myocardial infarction (AMI) constitutes an unmet need in current daily clinical practice. We aimed to evaluate the predictive value of soluble urokinase-type plasminogen activator receptor (suPAR) levels… read more here.
Keywords: patients suspected; myocardial infarction; value; supar ... See more keywords
Soluble Urokinase-Type Plasminogen Activator Receptor and Inflammatory Biomarker Response with Prognostic Significance after Acute Neuronal Injury – a Prospective Cohort Study
Sign Up to like & getrecommendations! Published in 2024 at "Inflammation"
DOI: 10.1007/s10753-024-02185-1
Abstract: Aneurysmal subarachnoid hemorrhage (aSAH), ischemic stroke (IS), and traumatic brain injury (TBI) are severe conditions impacting individuals and society. Identifying reliable prognostic biomarkers for predicting survival or recovery remains a challenge. Soluble urokinase type plasminogen… read more here.
Keywords: brain injury; injury; supar; study ... See more keywords
Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of diabetes and its complications"
DOI: 10.1016/j.jdiacomp.2019.06.001
Abstract: BACKGROUND Endothelial dysfunction caused by chronic inflammation is the cornerstone of vascular complications in type 1 Diabetes-Mellitus (T1DM). Soluble Urokinase Plasminogen Activator Receptor (SuPAR) is a novel marker of inflammation and endothelial dysfunction. AIM To… read more here.
Keywords: vascular complications; urokinase plasminogen; plasminogen activator; activator receptor ... See more keywords
Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of early pregnancy location and viability compared with hCG, progesterone and estradiol.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of reproductive immunology"
DOI: 10.1016/j.jri.2020.103103
Abstract: A circulating biomarker of early pregnancy outcome independent of ultrasonography and gestational age is a coveted goal. This study evaluated soluble urokinase plasminogen activator receptor (suPAR), a well-described marker of inflammation and immunological activation, for… read more here.
Keywords: pregnancy; pregnancy location; early pregnancy; supar ... See more keywords
Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-96352-1
Abstract: Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory biomarker and risk factor for kidney diseases, with a potential prognostic value in critically ill patients. In this monocentric prospective study, we measured plasma suPAR levels… read more here.
Keywords: sofa score; urokinase plasminogen; supar; plasminogen activator ... See more keywords
Soluble urokinase plasminogen activator receptor and functionally relevant coronary artery disease: a prospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Biomarkers"
DOI: 10.1080/1354750x.2022.2038269
Abstract: Abstract Background Soluble urokinase plasminogen activator receptor (suPAR) is an emerging biomarker associated with anatomical CAD burden and cardiovascular outcomes including myocardial infarction (MI) and death. We aimed to validate previous findings of the prognostic… read more here.
Keywords: urokinase plasminogen; activator receptor; plasminogen activator; death ... See more keywords
The use of soluble urokinase plasminogen activator receptor (suPAR) as a marker of sepsis in the emergency department setting. A current review
Sign Up to like & getrecommendations! Published in 2019 at "Acta Clinica Belgica"
DOI: 10.1080/17843286.2019.1653519
Abstract: ABSTRACT Aim: The purpose of this review is to summarize all relevant publications regarding the use and validity of the soluble urokinase plasminogen activator receptor (suPAR) when used by clinicians in the emergency department (ED)… read more here.
Keywords: urokinase plasminogen; sepsis; activator receptor; supar ... See more keywords
B-070 Supar: what UACR and GFR don't say…
Sign Up to like & getrecommendations! Published in 2024 at "Clinical Chemistry"
DOI: 10.1093/clinchem/hvae106.432
Abstract: Soluble urokinase-type plasminogen activator receptor (suPAR) is the circulating form of a three domain membrane protein expressed on a variety of cells, including immunologically active cells, endothelial cells, and podocytes. Diabetic nephropathy (DN) typically manifests… read more here.
Keywords: according kdigo; category; supar levels; risk ... See more keywords
MO648SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH DIABETIC KIDNEY DISEASE
Sign Up to like & getrecommendations! Published in 2021 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfab094.0016
Abstract: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease worldwide, associated with significant cardiovascular morbidity and mortality. Soluble urokinase plasminogen activator receptor (suPAR) is a novel biomarker associated with inflammation, endothelial dysfunction… read more here.
Keywords: serum; level; disease; kidney ... See more keywords